Adverse events142

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 142

Type	Event	Organ system	Group	Affected	At risk	Events
other	Diarrhoea	Gastrointestinal disorders	V260 With Staggered or Concomitant EPI	406	2,015	487
other	Diarrhoea	Gastrointestinal disorders	Placebo With Staggered or Concomitant EPI	406	2,019	504
other	Pyrexia	General disorders	V260 With Staggered or Concomitant EPI	414	2,015	492
other	Pyrexia	General disorders	Placebo With Staggered or Concomitant EPI	419	2,019	481
other	Nasopharyngitis	Infections and infestations	V260 With Staggered or Concomitant EPI	228	2,015	248
other	Nasopharyngitis	Infections and infestations	Placebo With Staggered or Concomitant EPI	233	2,019	268
other	Upper respiratory tract infection	Infections and infestations	V260 With Staggered or Concomitant EPI	91	2,015	98
other	Upper respiratory tract infection	Infections and infestations	Placebo With Staggered or Concomitant EPI	103	2,019	114
other	Cough	Respiratory, thoracic and mediastinal disorders	V260 With Staggered or Concomitant EPI	115	2,015	133
other	Cough	Respiratory, thoracic and mediastinal disorders	Placebo With Staggered or Concomitant EPI	92	2,019	109
serious	Agranulocytosis	Blood and lymphatic system disorders	V260 With Staggered or Concomitant EPI	1	2,015	1
serious	Agranulocytosis	Blood and lymphatic system disorders	Placebo With Staggered or Concomitant EPI	0	2,019	0
serious	Anaemia	Blood and lymphatic system disorders	V260 With Staggered or Concomitant EPI	1	2,015	1
serious	Anaemia	Blood and lymphatic system disorders	Placebo With Staggered or Concomitant EPI	1	2,019	1
serious	Granulocytopenia	Blood and lymphatic system disorders	V260 With Staggered or Concomitant EPI	1	2,015	1
serious	Granulocytopenia	Blood and lymphatic system disorders	Placebo With Staggered or Concomitant EPI	0	2,019	0
serious	Cardiomyopathy	Cardiac disorders	V260 With Staggered or Concomitant EPI	1	2,015	1
serious	Cardiomyopathy	Cardiac disorders	Placebo With Staggered or Concomitant EPI	1	2,019	1
serious	Developmental hip dysplasia	Congenital, familial and genetic disorders	V260 With Staggered or Concomitant EPI	1	2,015	1
serious	Developmental hip dysplasia	Congenital, familial and genetic disorders	Placebo With Staggered or Concomitant EPI	0	2,019	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02062385/events

API reference For AI assistants

Adverse events142

Sources 3

Read this list from software.